‘Strawberry Fair’ Across P&O Cruises Fleet Joins Guests in Standing Behind Local Strawberry Producers

Mon, 09/24/2018 - 16:00

As Australia’s homegrown cruise line and a major purchaser of Australian strawberries, P&O Cruises is joining guests in backing Australia’s strawberry producers during the current challenging period. A special ‘strawberry fair’ is being held across all five ships in the P&O fleet this weekend with guests having the choice of a wide selection of strawberry desserts on display in the Sugar Bar in the ships’ Pantry food outlet.

Companies Step up Support in Wake of Hurricane Florence

Mon, 09/24/2018 - 11:50

Here’s a roundup of companies that took a distinctive approach to Hurricane Florence relief:

Blackbaud’s CMO Catherine LaCour Reflects on Blackbaud’s Sustainable Development Goals Commitments

Mon, 09/24/2018 - 09:05

Read about how Blackbaud is supporting the SDGs through technology, partnership, thought leadership and CSR efforts.

When Disaster Strikes: Companies Plan for Employee Catastrophic Assistance

Tue, 03/13/2018 - 10:55

Smithfield Foods Supports Hurricane Florence Disaster-Relief Efforts in North Carolina

Fri, 09/21/2018 - 14:15

Following historic flooding and devastation in North Carolina in the wake of Hurricane Florence, Smithfield Foods, Inc. is donating 480,000 servings of protein through its Helping Hungry Homes® initiative to two local food banks and has committed $100,000 to the American Red Cross to support ongoing disaster-relief and recovery efforts in the state.

Pro Bono Perspectives Podcast: Episode 2 - Gary Levante, Berkshire Bank

Tue, 09/25/2018 - 10:00

We are thrilled to welcome Gary Levante, Vice President of Corporate Responsibility at Berkshire Bank to Pro Bono Perspectives. Gary leads community engagement and sustainability for Berkshire Bank and under his leadership, Berkshire has earned more than two dozen accolades for its work, recently highlighted by a 100% participation rate in its corporate volunteer program.

AEG Raises More Than $60,000 for Pediatric Cancer Research at Children’s Hospital Los Angeles Through Company-Sponsored Nautica Malibu Triathlon Team

Fri, 09/21/2018 - 12:00

In a combined effort to advance its employees’ health and well-being and continue its longstanding support of Children’s Hospital Los Angeles (CHLA), AEG – the world’s leading sports and live entertainment company – raised more than $60,000 for CHLA through its involvement with the Nautica Malibu Triathlon on Sunday, Sept. 16 in Malibu, Calif.

Book Excerpt: Waging Justice

Mon, 09/24/2018 - 15:15

From the devastating wildfires racing through northern California to the hurricanes that slammed into Puerto Rico and Texas to daily challenges to democracy, we are constantly reminded we are living in a time of major environmental, social, and geopolitical upheaval. As a doctor, activist, advocate for global justice, and now a storyteller, Dr. Paul Zeitz offers a clear vision for the future in his debut memoir.

Landfill Solutions

Mon, 10/01/2018 - 12:00

People use multiple adjectives when describing a landfill, and they’re usually not anything related to “community asset.” At Republic, we’re working to change that perception. We want everyone to know that landfills play a fundamental role in protecting our planet and helping communities grow, revitalize and prosper.

Go Get the (Immune Cell) Regulators!

Wed, 09/26/2018 - 10:45

The shortage of donor beta cells and the need for strong immunosuppressive drugs to prevent immune attack make beta cell replacement available only to people with severe life-threatening unawareness of their low blood sugar, called hypoglycemia. At JDRF, we are taking a new route to beta cell replacement technologies, with the aim to develop an unlimited source of insulin-producing cells without drugs that limit your immune system’s role in fighting off infection.

One avenue, which Shugo Sasaki, M.D., Ph.D., is pursuing with a postdoctoral fellowship from JDRF, is to use gene editing. More specifically, Dr. Sasaki wants to investigate beta cells that have been edited to make a molecule that attracts “good” immune cells, called regulatory T cells, and whether the transplanted beta cells ar